A Study of IVX-A12 in Adults Participants

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2024
The primary purpose of this study is to assess the immunogenicity and safety of IVX-A12 in adults 60 years of age and older.
Epistemonikos ID: 6271bab225ab704b91a0d3ccd3a928493520a3ce
First added on: Apr 17, 2025